Target Peak Sales
Consulting Insight: Peak sales modeled at 100% market penetration. This is the un-risk-adjusted ceiling.
$850M
Risk-Adjusted NPV
Consulting Insight: Net Present Value factors in the delay to launch (10% discount rate) and the Probability of Success. Delays aggressively destroy NPV.
$320M
Post-Launch Revenue Curve (10 Year Horizon)
Total Time to Launch
Consulting Insight: The cumulative duration of Phase 1 through Phase 3, heavily impacted by patient recruitment rates.
78 Months
Recruitment Delay Impact
+0 Months
Phase 1
Phase 2
Phase 3
Launch
+2 YRS
+4 YRS
+6 YRS
+8 YRS
Cumulative Probability of Success (PoS)
Consulting Insight: The statistical likelihood of reaching approval. Slower recruitment indicates poor trial design or site selection, which correlates with trial failure.
15.0%
Patient Recruitment Velocity
Impact on Phase 2 & 3 schedules
Nominal
NPV Decay Rate
Value lost due to time-value of money
Standard
Static Slide Decks are Obsolete: This is a functional MVP demonstrating Lonrú Studios' rapid prototyping capability. Traditional consultants give you a PDF of this math; we build you the reactive dashboard to control it.